SCHEMBL7214872

SCHEMBL7214872

[CH2]c1c(C)cncc1OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
MAPT P10636 1/20 0.50
MAPK1 P28482 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
STAT3 P40763 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LIPE Q05469 1/20 0.42
IDO1 P14902 1/20 0.42
LTA4H P09960 1/20 0.41
MAPK14 Q16539 1/20 0.41
BRD4 O60885 4/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41
ABCB1 P08183 1/20 0.41
HTR1A P08908 3/20 0.40
FFAR4 Q5NUL3 1/20 0.40
ADRA1D P25100 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7214874 0.83 L3MBTL1 (0.58) AOC3L3MBTL1MAPTMAPK1TDP1
SCHEMBL12862698 0.77 MAPT (0.53) AOC3L3MBTL1MAPTMAPK1TDP1
Ammonia Solution, Strong SCHEMBL28403781 0.75 MAPT (0.51) AOC3L3MBTL1MAPTMAPK1TDP1
SCHEMBL26985270 0.74 AOC3 (0.55) AOC3L3MBTL1MAPTMAPK1TDP1
SCHEMBL10101799 0.74 MAPT (0.47) AOC3L3MBTL1MAPTMAPK1TDP1
SCHEMBL15373873 0.73 AOC3 (0.44) AOC3L3MBTL1MAPTMAPK1TDP1
Propionic Acid SCHEMBL29144216 0.73 AOC3 (0.47) AOC3L3MBTL1MAPTMAPK1TDP1
SCHEMBL28749497 0.72 AOC3 (0.52) AOC3L3MBTL1MAPTMAPK1TDP1
SCHEMBL112286 0.72 P4HTM (0.44) AOC3L3MBTL1MAPTMAPK1TDP1
SCHEMBL15064968 0.71 AOC3 (0.59) AOC3L3MBTL1MAPTMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6503898-B1 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-01-07 US disclosed